breaking high, NICE ENTRY POINT FOR BUYINGGREAT breaking resistence level, for swing trade. good Risk Reward
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.887 CHF
1.18 B CHF
5.06 B CHF
579.76 M
About Edwards Lifesciences Corporation
Sector
Industry
CEO
Bernard J. Zovighian
Website
Headquarters
Irvine
Founded
1958
FIGI
BBG00C5YWSN1
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
(EW) edward lifesciencesblood company, they have a warehouse based here in Utah, only reason I know of the company; as it turns out they did reach an all-time high and drop. Too bad. Wonder what happened? They were doing so well.
Buy at 86,19 after the rejectionTHIS IS NOT SHORT IDEA!!! Expecting a fall to 86,19 and rejection back to the final target. Enter just after clear rejection on 4H chart. Then set conditional SL, if any two 4H candles closes below the SL zone, cutloss your trade. No rejection at 86,19 = no trade. Don´t fall to the trap by buying lo
EW Flagging Just Under Major PivotEW is flagging beautifully just under the major $87 pivot. Made two nice gaps up after a similar flag broke to the upside. Showing great relative strength on a nasty market day as well. Target $95
Edwards Stop Buy placedAs seen on the chart - stop buy order placed. If the next bullish move comes I take it to the next level ....
Edwards Lifesciences - A Fine Enterprise
How to summarize this business ?
Rising earnings with high profit margins and low debt over long period of time.
***
EPS has grown from 0.3 in 2010 to 2.48 in 2022, with average profit margin of 22% for the past 7 years. Equity has been growing from 1.9 in 2010 to 9.5 in 2022 (book value per sha
Bullish Alert : EW15 minutes chart.
Bulish Alert with bullish crossover.
The downtrend is still valid but this time there is a small pullback on the ema 21.
Waiting for a new high
Edwards Lifesciences (EW) - Frequency Formula Strategy - ShortStrategy Overview: The Frequency Formula
Our trading strategy, "The Frequency Formula," is built on cutting-edge Fourier Wave Transform theory. The strategy utilizes four unique indicators: the Frequency Formula Chop Indicator (FF-CI), Frequency Formula Trend Indicator (FF-TI), the Frequency Formu
$EW with a Bullish outlook following its earnings #Stocks The PEAD projected a bullish outlook for $EW after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 66.67%.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EWL is 58.252 CHF — it has decreased by −0.38% in the past 24 hours. Watch EDWARDS LIFESCIENC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange EDWARDS LIFESCIENC stocks are traded under the ticker EWL.
EWL stock has fallen by −0.38% compared to the previous week, the month change is a −29.97% fall, over the last year EDWARDS LIFESCIENC has showed a −15.30% decrease.
We've gathered analysts' opinions on EDWARDS LIFESCIENC future price: according to them, EWL price has a max estimate of 79.60 CHF and a min estimate of 55.72 CHF. Watch EWL chart and read a more detailed EDWARDS LIFESCIENC stock forecast: see what analysts think of EDWARDS LIFESCIENC and suggest that you do with its stocks.
EWL stock is 0.38% volatile and has beta coefficient of 1.25. Track EDWARDS LIFESCIENC stock price on the chart and check out the list of the most volatile stocks — is EDWARDS LIFESCIENC there?
Today EDWARDS LIFESCIENC has the market capitalization of 36.27 B, it has increased by 0.97% over the last week.
Yes, you can track EDWARDS LIFESCIENC financials in yearly and quarterly reports right on TradingView.
EDWARDS LIFESCIENC is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
EWL earnings for the last quarter are 0.57 CHF per share, whereas the estimation was 0.56 CHF resulting in a 0.81% surprise. The estimated earnings for the next quarter are 0.49 CHF per share. See more details about EDWARDS LIFESCIENC earnings.
EDWARDS LIFESCIENC revenue for the last quarter amounts to 1.15 B CHF, despite the estimated figure of 1.31 B CHF. In the next quarter, revenue is expected to reach 1.21 B CHF.
EWL net income for the last quarter is 2.60 B CHF, while the quarter before that showed 329.32 M CHF of net income which accounts for 690.21% change. Track more EDWARDS LIFESCIENC financial stats to get the full picture.
No, EWL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 19.80 K employees. See our rating of the largest employees — is EDWARDS LIFESCIENC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EDWARDS LIFESCIENC EBITDA is 1.48 B CHF, and current EBITDA margin is 30.22%. See more stats in EDWARDS LIFESCIENC financial statements.
Like other stocks, EWL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EDWARDS LIFESCIENC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EDWARDS LIFESCIENC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EDWARDS LIFESCIENC stock shows the strong sell signal. See more of EDWARDS LIFESCIENC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.